proton pump inhibitor
STABILITY ENHANCEMENT OF PROTON PUMP INHIBITOR IN STOMACH: FORMULATION AND IN VITRO EVALUATION OF STABILIZED PROTON PUMP INHIBITOR
... Conclusion: The tablet formulated with croscarmellose sodium as superdisintegrant showed 97% drug release within 60 minutes. The optimized tablets were found to be stable in accelerated study conditions for 1 month with ...
5
Esophageal Strictures during Treatment with a Proton Pump Inhibitor
... - Gastroscopy was performed during the procedure [4] and did not reveal signs of esophagitis. The gastrostomy procedure and the postoperative course were uneventful. The patient occasionally developed leakage, ...
7
Proton Pump Inhibitor Side Effects Long Term
... protein pump inhibitor side effects term kidney damage tissues in the father, these increased ...the proton pump inhibitor side effects term ppi use and when needed for a ...of ...
5
Micronutrient Consequences of Long Term Proton Pump Inhibitor Therapy
... 1. INTRODUCTION PPIs have been a remarkable success story. Omeprazole was the first proton-pump inhibitor to be introduced in Europe in 1988. It was quickly shown to be superior to all previously ...
7
Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
... Abstract: A significant percentage of patients with gastroesophageal reflux disease (GERD) will not respond to proton pump inhibitor (PPI) therapy. The causes of PPI-refractory GERD are numerous and ...
16
Formulation and optimization of oro dispersible tablet of rabeprazole sodium as proton pump inhibitor
... The stability of rabeprazole sodium is function of pH; it is rapidly degraded in acid media, and is more stable under alkaline condition (VL. Kulkarni et al., 2006). It belongs to a class of antisecretory compounds that ...
5
Proton pump inhibitor prescribing patterns in the UK: a primary care database study
... of proton pump inhibitor recommendations at hospital discharge and continuation in primary ...of proton pump inhibitors in patients on long-term therapy: a double-blind, ...
26
Tapered Withdrawal of a Proton Pump Inhibitor to Prevent Rebound Acid-Related Symptoms
... Previous clinical studies have shown that withdrawal of PPI therapy is difficult to achieve, possibly due to recurrence of the underlying acid-related disease but also as a result of physiologic changes triggered by PPI ...
5
Formulation development of enteric coated tablets of a proton pump inhibitor for stability enhancement
... _________________________________________________________________________________________ ABSTRACT In the present investigation enteric coated formulation of proton pump inhibitor which is a ...
5
Formulation and Optimization of Oro dispersible Tablet of Pentoprazole Sodium as Proton Pump Inhibitor
... Class: Proton Pump Inhibitor The proton pump inhibitors are a group of drugs that reduce the secretion of gastric (stomach) ...the proton pump inhibitors reduce stomach ...
12
Clinicopathologic Analysis of Proton Pump Inhibitor-Responsive Esophageal Eosinophilia in Korean Patients
... Background/Aims: Proton pump inhibitor-responsive esophageal eosinophilia (PPI-REE) is a newly recognized form of eosinophilic esophagitis (EoE) that responds to PPI ...
5
Proton Pump Inhibitor Use and Increased Risk for Bone Fracture: A Literature Review
... time. Proton pump inhibitor use has increased dramatically in recent years, especially among geriatric populations, but they are also being prescribed to children and young adults for non-specific ...
16
Meta-analysis: the influence of pre-treatment with a proton pump inhibitor on Helicobacter pylori eradication
... Another factor that has been implicated in therapy failure is pre-treatment with a proton pump inhibitor (PPI). This may be an important factor as many patients treated for H. pylori infection are ...
5
Current Diagnosis and Management of Suspected Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy
... Is the proton pump inhibitor dose insufficient to con- trol acid reflux? As previously discussed, this is rarely the case with double-dose PPIs. A retrospective study from the Cleveland Clinic found ...
9
The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model
... ABSTRACT Proton pump inhibitor (PPI) use has been associated with microbiota al- terations and susceptibility to Clostridioides difficile infections (CDIs) in ...
7
Awareness, attitude and behavior regarding proton pump inhibitor among medical staff in the Southwest of China
... of proton pump inhibitor prescribing in US emergency ...of proton pump inhibitors within the Scottish National Health Service: their effect and ...
9
Review Article An updated meta-analysis: the effect of proton pump inhibitor on risk of osteoporosis and fracture
... Departments of 1 Gastroenterology, 2 Rheumatism, the First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi Province, China; 3 Department of Ultrasonography, the Affiliated Hospital of Jining Medical ...
17
Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility
... Background: The role of the gut microbiome in arresting pathogen colonization and growth is important for protection against Clostridium difficile infection (CDI). Observational studies associate proton ...
11
Proton Pump Inhibitor and Histamine 2 Receptor Antagonist Use and Vitamin B 12 Deficiency
... Proton Pump Inhibitor and Histamine 2 Receptor Antagonist Use and Vitamin B 12 Deficiency Jameson R. Lam, MPH; Jennifer L. Schneider, MPH; Wei Zhao, MPH; Douglas A. Corley, MD, PhD V itamin B 12 ...
8
Incremental cost-effectiveness and tolerability of Diclofenac + Proton pump inhibitor compared to tramadol in the treatment of knee osteoarthritis
... provisions, economic evaluation for management of diseases is meaningful. The main oral pharmacological options currently used to treat pain caused by OA include paracetamol, non- steroidal anti-inflammatory drugs ...
7